Answers are grounded in this paper and cite their sources.
Cholestasis is a pathological condition characterized by impaired bile flow. Key events contributing to cholestatic liver injury can be categorized into an adverse or an adaptive response, with both closely linked to changes in the bile acid pool. In this regard, the intracellular accumulation of bile acids is considered an essential and central key event within the adverse outcome pathway. A systematic understanding of bile acid profiles in vitro is of critical importance for advancing insights into the mechanistic complexity of cholestasis, and for supporting the informed development and application of human-relevant new approach methodologies. This study aimed to document bile acid profiles reported in simple human 2D and 3D hepatic in vitro models across temporal, spatial, and contextual dimensions. A dataset was compiled based on a systematic PubMed search including peer-reviewed research articles reporting in vitro bile acid concentrations across studies, cell models, cellular locations, and bile acid species. Quantitative treatment effects were assessed using log2-transformed treated-to-control ratios and visualized as heatmaps. Primary human hepatocytes, and human hepatoma cell lines HepaRG® and HepG2, were utilized to a comparable extent and conjugated bile acids were most frequently assessed. Patterns identified following chemical exposure were broadly consistent with the AOP framework and may have relevance as mechanistic markers. However, the fragmented and heterogeneous nature of the available data hampers precise and comprehensive identification of consistent patterns within specific experimental scenarios, indicating that a substantially larger body of evidence is needed together with the standardization of analytical procedures for bile acid quantification.
No takes yet. Share an insight, caveat, or question.
Maerten et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: